In this issue:
Haemophilia protective against cardiovascular morbidity
High risk for thrombosis in POEMS syndrome
Management strategies and clinical outcomes in IVC thrombosis
Antibody targeting mutant CALR may offer a therapy for MPNs
Gene therapy induces endogenous FVIII activity in severe haemophilia A
Antithrombotic use during endovascular stroke therapy risky
Use of apixaban vs warfarin in TAPS increases risk of stroke
COVID vaccination safe in patients with ITP
High rate of residual thrombi one year after acute PE
Efficacy and safety of aspirin for primary CV risk prevention
Please login below to download this issue (PDF)